VEGFA and breast carcinoma: A significant correlation between VEGF-A (-460T>C) genotypes in breast cancer patients with respect Tamoxifen treatment was revealed (p=0.005) and also a significant association of VEGF-A (-460T>C) genotypes in breast cancer patients with Trastuzumab or Herceptin treatment was reported (p=0.026).